CORIS BIOCONCEPT

Active

Private limited companyfounded 1996active for 30 yearsRue Guillaume Fouquet,Isnes 11, 5032 Gembloux, BelgiumKBO/BCE: BE 0459.020.430

Summary

CORIS BIOCONCEPT has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €5.0m and a net result of -€391,631. Equity is shrinking by about 4.6% per year across the filed financial years. Its solvency ranks better than 68% of 46 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

CORIS BIOCONCEPTActiveChecked score 93/100

Risk analysis Report Compare

Activity

Nutrition and dietetics services

NACE 86995Wholesale of pharmaceutical and medical goods NACE 46460

3rd largest company by total assets in Gembloux, Health and social work sector2 sites

Size

€5.5mturnover 2026

Staff: 31.2 FTE
Equity: €5.0m
Loss: -€391,631

Financial health

93 Excellent Checked score 2026

Bankruptcy probabilitywithin 12 months: 0.1%

Structure

Parent: Coris Holdings · 100%

Dhirendra DubeyDirector
Harminder SinghDirector

2026 accounts 17 days early8 of 12 deeds summarised

Why 93raises riskLoss of €391,631, the second in a row (financial year 2026)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 5.44, cash €815,481Equity €5.0m (82.1% of total assets)Show the evidence

Checked score

Score 2026

93 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 47% of its sector peers (NACE 86, small)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 82.1% of total assets

Liquidity 65-11

short-term debt 12.9% · cash 13.3%

Profitability 46-1

return on assets -6.4%

Bankruptcy probability, 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,074 companies, NACE 86, small)

Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: < 0.1%▼ -0.1 percentage points vs 02-2025lowest value 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025highest value 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026

Credit of up to €460,000 on 30-day terms is acceptable

Liquidity ample (current ratio 5.44, compared with 5.39 in 2024, above the usual 1.5; short-term debt: 12.9% and cash: 13.3% of total assets), and 17.9% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 77% on solvency, 54% on liquidity and 10% on profitability.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Loss of €391,631, the second in a row (financial year 2026)

NBB · annual accounts

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 5.44, cash €815,481

NBB · annual accounts

Equity €5.0m (82.1% of total assets)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 14-10-2026, 17 days ahead of the deadline.

NBB · 9 filings

Deviation from the deadline

2026

17 days early

2024

56 days late

2023

20 days late

2022

29 days late

2021

30 days late

2020

79 days late

2019

115 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 45 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

14-10-2026 Annual accounts filedfinancial year 2026 · abbreviated…
30-12-2025 Amendment of the articles · MiscellaneousPower of attorney
25-09-2025 Annual accounts filedfinancial year 2024 · full…

Key points

Risk: 5 loss-making years in a rowloss financial year 2026 -€391,631 View
Caution: Among the weakest 5% on net resultsector median €89,392 · 46 companies -€391,631 View
Controlled by Coris Holdingsultimately: 3B BLACKBIO DX LIMITED 100% View
EU research moneyEU contribution €3.4m View

By topic

Financials

Financial year: 2026
Turnover: €5.5m
Loss: -€391,631
Solvency: 82.1%

Turnover▲ 4.4%

Net result

20232026

Go to Financials

Board & ownership

Board: 2 members
Parent: Coris Holdings · 100%

Dhirendra DubeyDirector
Harminder SinghDirector

Go to Board & ownership

Network & group

Group: 3B BLACKBIO DX LIMITED

Go to Network & group

Timeline

Events: 42
Since: 1998

24-09-2025Resignation: Christina Coughlin (director)
27-05-2025Annual accounts filed
17-12-2024Resignation: Tony Gardiner (director)

Go to Timeline

Company details

Sites: 2

Legal form: Private limited company
Activity: Nutrition and dietetics servicesNACE 86995
Founded: 16-10-1996
Year ends: 31-03
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 13

Financial year: From 1 January to 31 December
Annual meeting: Second Tuesday of June at 14:00
Purpose: “La conception,la mise au point,le développement,fa fabrication,ta validation,l'achat et la…” (deed in French)

Go to Articles of association

Key facts about CORIS BIOCONCEPT

What is the company number of CORIS BIOCONCEPT?: 0459.020.430. In Belgium the VAT number is the company number with BE in front: BE 0459.020.430.
Where is CORIS BIOCONCEPT based?: The registered office is at Rue Guillaume Fouquet,Isnes 11, 5032 Gembloux.Company details
What does CORIS BIOCONCEPT do?: According to the KBO register, the main activity is nutrition and dietetics services (NACE 86995).
What is the legal form of CORIS BIOCONCEPT?: Private limited company (BV).
When was CORIS BIOCONCEPT founded?: On 16-10-1996.
Is CORIS BIOCONCEPT still active?: Yes, CORIS BIOCONCEPT is an active enterprise in the KBO register.
How many employees does CORIS BIOCONCEPT have?: On average 31.2 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
What is the turnover of CORIS BIOCONCEPT?: €5.5m in financial year 2026, according to the filed annual accounts.
Is CORIS BIOCONCEPT profitable?: In financial year 2026, CORIS BIOCONCEPT made a loss of €391,631.
Where can I find the annual accounts of CORIS BIOCONCEPT?: CORIS BIOCONCEPT filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2026.